Journal of thoracic disease 2020 10.21037/jtd.2020.03.23
Adjuvant therapy in stage IIIA-N2 non-small cell lung cancer after neoadjuvant concurrent chemoradiotherapy followed by surgery
Shin1, S; Kim, HK; Cho, JH; Choi, YS; Kim, K; Kim, J; Zo, JI; Sun, JM; Ahn, MJ; Park, K; Pyo, H; Ahn, YC; Shim, YM

CANCERS 2020 10.3390/cancers12040925
Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer
Yoon1, HG; Oh, D; Ahn, YC; Noh, JM; Pyo, H; Cho, WK; Song, YM; Park, M; Hwang, NY; Sun, JM; Kim, HK; Zo, JI; Shim, YM

J THORAC ONCOL 2020 10.1016/j.jtho.2019.10.022
Asian Thoracic Oncology Research Group Expert Consensus Statement on Optimal Management of Stage III NSCLC
Tan1, WL; Chua, KLM; Lin, CC; Lee, VHF; Tho, LM; Chan, AW; Ho, GF; Reungwetwattana, T; Yang, JC; Kim, DW; Soo, RA; Ahn, YC; Onishi, H; Ahn, MJ; Mok, TSK; Tan, DSW; Yang, F

ANN ONCOL 2020 10.1016/j.annonc.2019.10.026
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS
Park1, K; Vansteenkiste, J; Lee, KH; Pentheroudakis, G; Zhou, C; Prabhash, K; Seto, T; Voon, PJ; Tan, DSW; Yang, JCH; Wang, J; Babu, KG; Nakayama, Y; Alip, A; Chua, KLM; Cheng, JCH; Senan, S; Ahn, YC; Kim, TY; Ahn, HK; Peters, S; Yoshino, T; Douillard, JY

HEAD NECK-J SCI SPEC 2020 10.1002/hed.26067
Prevalence of NUT carcinoma in head and neck: Analysis of 362 cases with literature review
Lee1, T; Cho, J; Baek, CH; Son, YI; Jeong, HS; Chung, MK; Hong, SD; Ahn, YC; Oh, DR; Noh, JM; Park, K; Ahn, MJ; Kim, HJ; Kim, YK; Ko, YH

RESP RES 2020 10.1186/s12931-019-1254-0
Impact of diffusing lung capacity before and after neoadjuvant concurrent chemoradiation on postoperative pulmonary complications among patients with stage IIIA/N2 non-small-cell lung cancer
Shin1, S; Choi, YS; Jung, JJ; Im, Y; Shin, SH; Kang, D; Cho, JH; Kim, HK; Kim, J; Zo, JI; Shim, YM; Park, K; Ahn, MJ; Ahn, YC; Lee, G; Cho, J; Lee, HY; Park, HY

Journal of thoracic disease 2019 10.21037/jtd.2019.10.18
Improved clinical outcomes following additional aggressive local consolidative therapy to systemic therapy for oligometastasis from lung cancer: where do we stand between "reality" and "illusion"?
Nam1, H; Noh, JM; Park, SG; Ahn, YC

INT J RADIAT ONCOL 2019 10.1016/j.ijrobp.2019.06.2540
International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma
Lee1, AW; Ng, WT; Pan, JJ; Chiang, CL; Poh, SS; Choi, HC; Ahn, YC; AlHussain, H; Corry, J; Grau, C; Gregoire, V; Harrington, KJ; Hu, CS; Kwong, DL; Langendijk, JA; Le, QT; Lee, NY; Lin, JC; Lu, TX; Mendenhall, WM; O'Sullivan, B; Ozyar, E; Peters, LJ; Rosenthal, DI; Sanguineti, G; Soong, YL; Tao, YA; Yom, SS; Wee, JT

Int J Chron Obstruct Pulmon Dis 2019 10.2147/COPD.S210759
Impact Of Underlying Pulmonary Diseases On Treatment Outcomes In Early-Stage Non-Small Cell Lung Cancer Treated With Definitive Radiotherapy
Kim1, H; Yoo, H; Pyo, H; Ahn, YC; Noh, JM; Ju, SG; Lee, W; Park, B; Kim, JM; Kang, N; Shin, SH; Chung, MP; Shin, S; Kim, HS; Park, M; Park, HY

CANCER SCI 2019 10.1111/cas.14115
Early clinical outcomes of helical tomotherapy/intensity-modulated proton therapy combination in nasopharynx cancer
Park1, SG; Ahn, YC; Oh, D; Noh, JM; Ju, SG; Kwon, D; Jo, K; Chung, K; Chung, E; Lee, W; Park, S

J RADIAT RES 2019 10.1093/jrr/rrz040
Role of prophylactic cranial irradiation for elderly patients with limited-disease small-cell lung cancer: inverse probability of treatment weighting using propensity score
Kim1, TG; Pyo, H; Ahn, YC; Noh, JM; Oh, D

EUR J NUCL MED MOL I 2019 10.1007/s00259-019-04387-4
Diagnostic value of surveillance F-18-fluorodeoxyglucose PET/CT for detecting recurrent esophageal carcinoma after curative treatment
Kim1, SJ; Hyun, SH; Moon, SH; Lee, KS; Sun, JM; Oh, D; Ahn, YC; Zo, JI; Shim, YM; Choi, JY

CANCER RES TREAT 2019 10.4143/crt.2018.415
Dummy Run of Quality Assurance Program before Prospective Study of Hippocampus-Sparing Whole-Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases from Non-small Cell Lung Cancer: Korean Radiation Oncology Group (KROG) 17-06 Study
Chung1, E; Noh, JM; Lee, KC; Kim, JH; Chung, WK; Suh, YG; Lee, JA; Seol, KH; Wu, HG; Kim, YS; Noh, OK; Park, JW; Lee, DS; Lee, J; Kim, YS; Park, WY; Kang, MK; Jo, S; Ahn, YC

RADIAT ONCOL 2019 10.1186/s13014-019-1289-x
Development of a semi-customized tongue displacement device using a 3D printer for head and neck IMRT
Hong1, CS; Oh, D; Ju, SG; Ahn, YC; Na, CH; Kwon, DY; Kim, CC

CANCER RES TREAT 2019 10.4143/crt.2018.190
Radiation Therapy Outcome and Clinical Features of Duodenal-Type Follicular Lymphoma
Lee1, H; Oh, D; Yang, K; Ko, YH; Ahn, YC; Kim, WS; Kim, SJ

CANCER RES TREAT 2019 10.4143/crt.2018.125
EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
Park1, SE; Noh, JM; Kim, YJ; Lee, HS; Cho, JH; Lim, SW; Ahn, YC; Pyo, H; Choi, YL; Han, J; Sun, JM; Lee, SH; Ahn, JS; Park, K; Ahn, MJ

CANCER RES TREAT 2019 10.4143/crt.2018.366
Salvage Concurrent Chemo-radiation Therapy for Loco-regional Recurrence Following Curative Surgery of Non-small Cell Lung Cancer
Lee1, KH; Ahn, YC; Pyo, H; Noh, JM; Park, SG; Kim, TG; Lee, E; Nam, H; Lee, H; Sun, JM; Ahn, JS; Ahn, MJ; Park, K

CANCER RES TREAT 2019 10.4143/crt.2018.240
Feasibility of Selective Neck Irradiation with Lower Elective Radiation Dose in Treating Nasopharynx Cancer Patients
Cho1, WK; Oh, D; Lee, E; Kim, TG; Lee, H; Nam, H; Noh, JM; Ahn, YC

RADIOTHER ONCOL 2019 10.1016/j.radonc.2019.01.005
Dosimetric predictors for postoperative pulmonary complications in esophageal cancer following neoadjuvant chemoradiotherapy and surgery
Cho1, WK; Oh, D; Kim, HK; Ahn, YC; Noh, JM; Shim, YM; Zo, JI; Choi, YS; Sun, JM; Lee, SH; Ahn, MJ; Park, K; Nam, H

J RADIAT RES 2019 10.1093/jrr/rry102
Concurrent chemo-radiotherapy for unresectable non-small cell lung cancer invading adjacent great vessels on radiologic findings: is it safe?
Yoo1, GS; Oh, D; Pyo, H; Ahn, YC; Noh, JM; Park, HC; Lim, DH

CANCER RES TREAT 2019 10.4143/crt.2017.273
The Effect of Hospital Case Volume on Clinical Outcomes in Patients with Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Analysis (KROG-1106)
Ha1, B; Cho, KH; Moon, SH; Lee, CG; Keum, KC; Kim, YS; Wu, HG; Kim, JH; Ahn, YC; Oh, D; Noh, JM; Lee, JH; Kim, SH; Kim, WT; Oh, YT; Kang, MK; Kim, JH; Kim, JY; Cho, MJ; Kay, CS; Choi, JH

INT J RADIAT ONCOL 2018 10.1016/j.ijrobp.2018.07.2022
Patterns of Failure Following Postoperative Radiation Therapy Based on "Tumor Bed With Margin" for Stage II to IV Type C Thymic Epithelial Tumor
Lee1, KH; Noh, JM; Ahn, YC; Oh, D; Kim, J; Shim, YM; Han, JH

RADIAT ONCOL 2018 10.1186/s13014-018-1196-6
Clinical outcomes of radiation therapy for clinical T4b oesophageal cancer with airway invasion
Kim1, H; Oh, D; Ahn, YC; Park, K; Ahn, MJ; Lee, SH; Sun, JM; Shim, YM; Zo, JI; Choi, YS; Kim, HK; Cho, JH

CANCER RES TREAT 2018 10.4143/crt.2017.182
Low-Dose Radiation Therapy for Primary Conjunctival Marginal Zone B-Cell
Lee1, GI; Oh, D; Kim, WS; Kim, SJ; Ko, YH; Woo, KI; Kim, YD; Ahn, YC

LUNG CANCER 2018 10.1016/j.lungcan.2017.11.020
Recurrence dynamics after trimodality therapy (Neoadjuvant concurrent chemoradiotherapy and surgery) in patients with stage IIIA (N2) lung cancer
Lee1, J; Kim, HK; Park, BJ; Cho, JH; Choi, YS; Zo, JI; Shim, YM; Pyo, H; Ahn, YC; Ahn, JS; Ahn, MJ; Park, K; Kim, J

HEAD NECK-J SCI SPEC 2018 10.1002/hed.24980
Efficacy of postoperative neck irradiation for regional control in patients with pN0 oral tongue cancer: Propensity analysis
So1, YK; Oh, D; Choi, N; Baek, CH; Ahn, YC; Chung, MK

RADIOTHER ONCOL 2018 10.1016/j.radonc.2017.10.032
International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma
Lee1, AW; Ng, WT; Pan, JJ; Poh, SS; Ahn, YC; AlHussain, H; Corry, J; Grau, C; Gregoire, V; Harrington, KJ; Hu, CS; Kwong, DL; Langendijk, JA; Le, QT; Lee, NY; Lin, JC; Lu, TX; Mendenhall, WM; O'Sullivan, B; Ozyar, E; Peters, LJ; Rosenthal, DI; Soong, YL; Tao, YG; Yom, SS; Wee, JT

J THORAC ONCOL 2017 10.1016/j.jtho.2017.09.1954
Randomized Phase II Trial Comparing Chemoradiotherapy with Chemotherapy for Completely Resected Unsuspected N2-Positive Non-Small Cell Lung Cancer
Sun1, JM; Noh, JM; Oh, D; Kim, HK; Lee, SH; Choi, YS; Pyo, H; Ahn, JS; Jung, SH; Ahn, YC; Kim, J; Ahn, MJ; Zo, JI; Shim, YM; Park, K

JPN J CLIN ONCOL 2017 10.1093/jjco/hyx120
Whole brain radiation dose reduction for primary central nervous system lymphoma patients who achieved partial response after high-dose methotrexate based chemotherapy
Park1, JS; Lim, DH; Ahn, YC; Park, W; Kim, SJ; Kim, WS; Kim, K

RADIAT ONCOL 2017 10.1186/s13014-017-0905-x
Normal lung sparing Tomotherapy technique in stage III lung cancer
Hong1, CS; Ju, SG; Ahn, YC; Yoo, GS; Noh, JM; Oh, D; Chung, K; Pyo, H; Jo, K

CANCER RES TREAT 2017 10.4143/crt.2016.442
Role of Adjuvant Thoracic Radiation Therapy and Full Dose Chemotherapy in pN2 Non-small Cell Lung Cancer: Elucidation Based on Single Institute Experience
Park1, H; Oh, D; Ahn, YC; Pyo, H; Noh, JM; Sun, JM; Ahn, JS; Ahn, MJ; Park, K; Kim, HK; Choi, YS; Kim, J; Zo, JI; Shim, YM

CANCER RES TREAT 2017 10.4143/crt.2016.425
Comparison of the Clinical Outcomes of Patients with Squamous Cell Carcinoma of the Tonsil Receiving Postoperative Ipsilateral Versus Bilateral Neck Radiotherapy: A Propensity Score Matching Analysis (KROG 11-07)
Kim1, Y; Cho, KH; Moon, SH; Lee, CG; Keum, KC; Lee, SW; Ahn, YC; Oh, D; Kim, YS; Won, YK; Wu, HG; Hah, JH; Oh, YT

BMC CANCER 2017 10.1186/s12885-017-3571-3
Chemoradiotherapy versus surgery followed by postoperative radiotherapy in tonsil cancer: Korean Radiation Oncology Group (KROG) study
Song1, S; Wu, HG; Lee, CG; Keum, KC; Kim, MS; Ahn, YC; Oh, D; Park, HJ; Lee, SW; Park, G; Moon, SH; Cho, KH; Kim, YS; Won, Y; Oh, YT; Kim, WT; Jeong, JU

CANCER RES TREAT 2017 10.4143/crt.2016.219
Survey of the Patterns of Using Stereotactic Ablative Radiotherapy for Early-Stage Non-small Cell Lung Cancer in Korea
Song1, S; Chang, JH; Kim, HJ; Kim, YS; Kim, JH; Ahn, YC; Kim, JS; Song, SY; Moon, SH; Cho, MJ; Youn, SM

Pathol Res Pract. 2017 Feb;213(2):106-112. doi: 10.1016/j.prp.2016.11.012. Epub 2016 Nov 15.
Histologic characteristics of thymic adenocarcinomas: Clinicopathologic study of a nine-case series and a review of the literature
Kwon AY11, Han J2, Chu J1, Choi YS3, Jeong BH4, Ahn MJ5, Ahn YC6.

RADIOTHERAPY AND ONCOLOGY, FEB 2017, 122(2):217-223, DOI: 10.1016/j.radonc.2016.09.015
A phase II trial of concurrent chemoradiotherapy with weekly docetaxel plus cisplatin treatment for unresectable locally advanced head and neck cancer
Lee JY1, Sun JM, Oh D, Lim SH, Chi S, Lee SH, Jung SH, Ahn MJ, Ahn YC, Park K

Oncotarget. 2017 Jan 10;8(2):3542-3552. doi: 10.18632/oncotarget.12200.
Supraclavicular and/or celiac lymph node metastases from thoracic esophageal squamous cell carcinoma did not compromise survival following neoadjuvant chemoradiotherapy and surgery
Cho WK11, Oh D1, Ahn YC1, Shim YM2, Zo JI2, Sun JM3, Ahn MJ3, Park K3.

J Radiat Res. 2017 Jan;58(1):155-163. doi: 10.1093/jrr/rrw089. Epub 2016 Sep 26.
Spine Metastasis Practice Patterns among Korean, Chinese, and Japanese Radiation Oncologists: A Multinational Online Survey Study
Yu JI11, Park HC2,3, Ahn YC1,3, Gao XS4, Wang JJ5, Zeng ZC6, Ito Y7, Ohno T8, Nishimura Y9.

J Thorac Oncol. 2016 Dec;11(12):2202-2207. doi: 10.1016/j.jtho.2016.07.005. Epub 2016 Jul 14.
Do New pN Subclassifications Proposed by IASLC's Lung Cancer Staging Project Agree with ypN Categories after Trimodality Therapy for Initial N2 Disease?
Kim H11, Ahn YC2, Pyo H1, Oh D1, Noh JM1, Sun JM3, Ahn JS3, Ahn MJ3, Park K3, Choi YS4, Kim J4, Zo JI4, Shim YM4, Lee M5, Han J5.

Ann Surg Oncol. 2016 Dec;23(13):4368-4375. Epub 2016 Jun 24.
Low-Grade Salivary Gland Cancers: Treatment Outcomes, Extent of Surgery and Indications for Postoperative Adjuvant Radiation Therapy
Cho JK11, Lim BW1, Kim EH2, Ko YH3, Oh D4, Noh JM4, Ahn YC4, Baek KH5, Jeong HS6.

BRITISH JOURNAL OF RADIOLOGY, 2016, 89(1067), DOI: 10.1259/bjr.20160109
Value of F-18-FDG heterogeneity for discerning metastatic from benign lymph nodes in nasopharyngeal carcinoma patients with suspected recurrence
Moon SH1, Cho YS, Son YI, Ahn YC, Ahn MJ, Choi JY, Kim BT, Lee KH

Cancer Res Treat. 2016 Oct;48(4):1187-1195. Epub 2016 Mar 9.
Radiation Therapy Alone in cT1-3N0 Non-small Cell Lung Cancer Patients Who Are Unfit for Surgical Resection or Stereotactic Radiation Therapy: Comparison of Risk-Adaptive Dose Schedules
Cho WK11, Noh JM1, Ahn YC1, Oh D1, Pyo H1.

Oncotarget. 2016 Sep 13;7(37):60639-60646. doi: 10.18632/oncotarget.10259.
Clinical significance of post-surgical residual tumor burden and radiation therapy in treating patients with lacrimal adenoid cystic carcinoma
Noh JM11, Lee E1, Ahn YC1, Oh D1, Kim YD2, Woo KI2, Ko YH3, Kim S3.

Otolaryngol Head Neck Surg. 2016 Sep;155(3):423-30. doi: 10.1177/0194599816642418. Epub 2016 Apr 5.
Randomized Trial of Vitamin C/E Complex for Prevention of Radiation-Induced Xerostomia in Patients with Head and Neck Cancer
Chung MK11, Kim do H2, Ahn YC3, Choi JY4, Kim EH1, Son YI5.

Medicine (Baltimore). 2016 Aug;95(33):e4591. doi: 10.1097/MD.0000000000004591.
High-dose radiation therapy alone by moderate hypofractionation for patients with thoracic esophageal squamous cell carcinoma
Oh D11, Noh JM, Nam H, Lee H, Kim TG, Ahn YC.

Cancer Res Treat. 2016 Jul;48(3):1102-9. doi: 10.4143/crt.2015.207. Epub 2015 Dec 2.
Variation in Practice Patterns of Korean Radiation Oncologists for Spine Metastasis between 2009 and 2014
Yu JI11, Park HC1,2, Ahn YC1,2, Chung Y1, Koom WS3, Song SY4.

Cancer Res Treat. 2016 Jul;48(3):917-27. doi: 10.4143/crt.2015.265. Epub 2015 Dec 28.
The Role of Neoadjuvant Chemotherapy in the Treatment of Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Study (KROG 11-06) Using Propensity Score Matching Analysis
Song JH11, Wu HG2, Keam BS3, Hah JH4, Ahn YC5, Oh D5, Noh JM5, Park HJ5, Lee CG6, Keum KC6, Cha J6, Cho KH7, Moon SH7, Kim JY8, Chung WK9, Oh YT10, Kim WT11, Cho MJ12, Kay CS13, Kim YS14.

Ann Surg Oncol. 2016 Jun;23(6):2054-61. doi: 10.1245/s10434-016-5088-4. Epub 2016 Jan 19.
Comparison of Oncological and Functional Outcomes between Initial Surgical versus Non-Surgical Treatments for Hypopharyngeal Cancer
Jang JY11, Kim EH2, Cho J2, Jung JH3, Oh D4, Ahn YC4, Son YI2, Jeong HS5.

Strahlenther Onkol. 2016 Jun;192(6):377-85. doi: 10.1007/s00066-016-0959-y. Epub 2016 Mar 14.
IMRT vs. 2D-radiotherapy or 3D-conformal radiotherapy of nasopharyngeal carcinoma Survival outcome in a Korean multi-institutional retrospective study (KROG 11-06)
Moon SH11, Cho KH2, Lee CG3, Keum KC3, Kim YS4, Wu HG5, Kim JH5, Ahn YC6, Oh D6, Lee JH7.

Lung Cancer. 2016 Jun;96:56-62. doi: 10.1016/j.lungcan.2016.03.016. Epub 2016 Mar 29.
Outcomes of neoadjuvant concurrent chemoradiotherapy followed by surgery for non-small-cell lung cancer with N2 disease
Kim HK11, Cho JH1, Choi YS1, Zo JI1, Shim YM1, Park K2, Ahn MJ2, Ahn YC3, Kim K4, Kim J5.

Cancer Res Treat. 2016 Apr;48(2):527-36. doi: 10.4143/crt.2015.249. Epub 2015 Sep 15.
Association between PD-L1 and HPV Status and the Prognostic Value of PD-L1 in Oropharyngeal Squamous Cell Carcinoma
Kim HS11, Lee JY1, Lim SH1, Park K1, Sun JM1, Ko YH2, Baek CH3, Son YI3, Jeong HS3, Ahn YC4, Lee MY5, Hong M6, Ahn MJ1.

Head Neck. 2016 Apr;38 Suppl 1:E293-9. doi: 10.1002/hed.23988. Epub 2015 Jun 26.
Fate of patients with nasopharyngeal cancer who developed distant metastasis as first failure after definitive radiation therapy
Chang JH11,2, Ahn YC1, Park H1, Oh D1, Noh JM1, Sun JM3, Ahn MJ3, Park K3.

Cancer Res Treat. 2016 Apr;48(2):537-45. doi: 10.4143/crt.2015.081. Epub 2015 Jul 14.
Tumor Volume Reduction Rate during Adaptive Radiation Therapy as a Prognosticator for Nasopharyngeal Cancer
Lee H11, Ahn YC2, Oh D2, Nam H1, Noh JM2, Park SY2,3.

Ann Hematol. 2016 Mar;95(4):581-91. doi: 10.1007/s00277-015-2581-y. Epub 2016 Jan 4.
Extra-nodal natural killer/T cell lymphoma in elderly patients: the impact of aging on clinical outcomes and treatment tolerability
Kim SM11, Park S1, Oh DR2, Ahn YC2, Ko YH3, Kim SJ1, Kim WS4.

Radiother Oncol. 2016 Feb;118(2):244-50. doi: 10.1016/j.radonc.2015.11.030. Epub 2015 Dec 17.
Comparison of weekly versus triweekly cisplatin delivered concurrently with radiation therapy in patients with locally advanced nasopharyngeal cancer: A multicenter randomized phase II trial (KCSG-HN10-02)
Lee JY11, Sun JM1, Oh DR2, Lim SH1, Goo J3, Lee SH1, Kim SB4, Park KU5, Kim HK6, Hong DS7, Kim JS8, Kim SG9, Yi SY10, Yun HJ11, Hyun MS12, Kim HJ13, Jung SH3, Park K1, Ahn YC14, Ahn MJ15.

Cancer Res Treat. 2016 Jan;48(1):63-70. doi: 10.4143/crt.2014.265. Epub 2015 Mar 6.
Carotid-Sparing TomoHelical 3-Dimensional Conformal Radiotherapy for Early Glottic Cancer
Hong CS11, Oh D1, Ju SG1, Ahn YC1, Noh JM1, Chung K1, Kim JS1, Suh TS2.

Eur J Cancer. 2016 Jan;52:1-9. doi: 10.1016/j.ejca.2015.09.019. Epub 2015 Nov 26.
Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer
Lim SH11, Hong M2, Ahn S3, Choi YL3, Kim KM3, Oh D4, Ahn YC4, Jung SH5, Ahn MJ1, Park K1, Zo JI6, Shim YM6, Sun JM7.

Cancer Res Treat. 2016 Jan;48(1):106-14. doi: 10.4143/crt.2014.131. Epub 2015 Feb 12.
Effect of Radiation Therapy Techniques on Outcome in N3-positive IIIB Non-small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
Noh JM11, Kim JM1, Ahn YC1, Pyo H1, Kim B1, Oh D1, Ju SG1, Kim JS1, Shin JS1, Hong CS1, Park H1, Lee E1.

Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):677-83. doi: 10.1016/j.ijrobp.2015.07.2267. Epub 2015 Jul 22.
Concurrent Chemoradiation Therapy Followed by Consolidation Chemotherapy for Localized Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
Oh D11, Ahn YC2, Kim SJ3, Kim WS3, Ko YH4.

Int Forum Allergy Rhinol. 2015 Oct;5(10):960-6. doi: 10.1002/alr.21564. Epub 2015 Jun 3.
Nasal endoscopic evaluation and its impact on survival in patients with stage I/II extranodal natural killer/T-cell lymphoma, nasal type
Cho HJ11, Jang MS2, Hong SD2, Kim SJ3, Ahn YC4, Oh D4, Ko YH5, Kim HY2, Dhong HJ2, Chung SK2, Kim WS3.

Radiother Oncol. 2015 Oct;117(1):171-7. doi: 10.1016/j.radonc.2015.08.009. Epub 2015 Aug 20.
Effects of adjuvant radiotherapy on completely resected gastric cancer: A radiation oncologist's view of the ARTIST randomized phase III trial
Yu JI11, Lim do H2, Ahn YC1, Lee J3, Kang WK3, Park SH3, Park JO3, Park YS3, Lim HY3, Kim ST3, Kim S4, Sohn TS4, Choi MG4, Bae JM4, Nam H5.

Cancer Res Treat. 2015 Oct;47(4):727-37. doi: 10.4143/crt.2014.018. Epub 2014 Dec 2.
Dosimetric and Clinical Influence of 3D Versus 2D Planning in Postoperative Radiation Therapy for Gastric Cancer
Lee JA11, Ahn YC2, Lim do H2, Park HC2, Asranbaeva MS3.

Cancer Res Treat. 2015 Oct;47(4):871-8. doi: 10.4143/crt.2014.141. Epub 2015 Feb 13.
Role of Chemotherapy in Stacie II Nasopharyngeal Carcinoma Treated with Curative Radiotherapy
Kang MK11, Oh D2, Cho KH3, Moon SH3, Wu HG4, Heo DS5, Ahn YC2, Park K6, Park HJ2, Park JS2, Keum KC7, Cha J7, Kim JW7, Kim YS8, Kang JH9, Oh YT10, Kim JY11, Kim SH12, Kim JH13, Lee CG7.

Cancer Res Treat. 2015 Oct;47(4):645-52. doi: 10.4143/crt.2014.144. Epub 2015 Feb 12.
Definitive Bimodality Concurrent Chemoradiotherapy in Patients with Inoperable N2-positive Stage IIIA Non-small Cell Lung Cancer
Noh JM11, Ahn YC1, Lee H2, Pyo H1, Kim B1, Oh D1, Park H1, Lee E1, Park K3, Ahn JS3, Ahn MJ3, Sun JM3.

AJR Am J Roentgenol.?2015 Sep;205(3):623-8. doi: 10.2214/AJR.14.13847.
Volume-Based Assessment With F-18-FDG PET/CT Improves Outcome Prediction for Patients With Stage IIIA-N2 Non-Small Cell Lung Cancer
Hyun SH11,?Ahn HK2,?Ahn MJ3,?Ahn YC4,?Kim J5,?Shim YM5,?Choi JY1.

J Clin Oncol. 2015 Aug 20;33(24):2660-6. doi: 10.1200/JCO.2014.60.0130. Epub 2015 Jul 6.
Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04
Ahn JS11, Ahn YC1, Kim JH1, Lee CG1, Cho EK1, Lee KC1, Chen M1, Kim DW1, Kim HK1, Min YJ1, Kang JH1, Choi JH1, Kim SW1, Zhu G1, Wu YL1, Kim SR1, Lee KH1, Song HS1, Choi YL1, Sun JM1, Jung SH1, Ahn MJ1, Park K2.

Cancer Res Treat.?2015 Jul;47(3):436-40. doi: 10.4143/crt.2013.184. Epub 2014 Nov 17.
Potential Role of Adjuvant Radiation Therapy in Cervical Thymic Neoplasm Involving Thyroid Gland or Neck
Noh JM11,?Ha SY2,?Ahn YC1,?Oh D1,?Seol SW1,?Oh YL2,?Han J2.

Eur J Cancer. 2015 Jul;51(10):1303-11. doi: 10.1016/j.ejca.2015.04.003. Epub 2015 Apr 28.
Development and external validation of nomograms predictive of response to radiation therapy and overall survival in nasopharyngeal cancer patients
Cho JK11, Lee GJ2, Yi KI3, Cho KS3, Choi N2, Kim JS2, Kim H4, Oh D4, Choi SK5, Jung SH5, Jeong HS2, Ahn YC6.

Clin Exp Otorhinolaryngol. 2015 Jun;8(2):142-8. doi: 10.3342/ceo.2015.8.2.142. Epub 2015 May 13.
Prognostic Value of Volume-Based Positron Emission Tomography/Computed Tomography in Patients With Nasopharyngeal Carcinoma Treated With Concurrent Chemoradiotherapy
Moon SH11, Choi JY1, Lee HJ1, Son YI2, Baek CH2, Ahn YC3, Ahn MJ4, Park K4, Kim BT1.

J Thorac Oncol.?2015 Feb;10(2):331-7. doi: 10.1097/JTO.0000000000000388.
Endobronchial Ultrasound versus Mediastinoscopy for Mediastinal Nodal Staging of Non-Small-Cell Lung Cancer
Um SW11,?Kim HK,?Jung SH,?Han J,?Lee KJ,?Park HY,?Choi YS,?Shim YM,?Ahn MJ,?Park K,?Ahn YC,?Choi JY,?Lee KS,?Suh GY,?Chung MP,?Kwon OJ,?Kim J,?Kim H

Cancer Chemother Pharmacol. 2015 Jan;75(1):77-85. doi: 10.1007/s00280-014-2619-1. Epub 2014 Nov 6.
Predictive factors for survival in stage IIIA N2 NSCLC patients treated with neoadjuvant CCRT followed by surgery
Lim HJ11, Lee HY, Lee KS, Han J, Kwon OJ, Park K, Ahn YC, Kim BT, Shim YM.

Ann Hematol. 2014 Nov;93(11):1895-901. doi: 10.1007/s00277-014-2137-6. Epub 2014 Jun 20.
Concurrent chemoradiotherapy followed by L-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study
Kim SJ11, Yang DH, Kim JS, Kwak JY, Eom HS, Hong DS, Won JH, Lee JH, Yoon DH, Cho J, Nam TK, Lee SW, Ahn YC, Suh C, Kim WS.

Clin Lung Cancer. 2014 Sep;15(5):346-55. doi: 10.1016/j.cllc.2014.04.003. Epub 2014 May 15.
An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non-Small-Cell Lung Cancer
Ashworth AB11, Senan S2, Palma DA1, Riquet M3, Ahn YC4, Ricardi U5, Congedo MT6, Gomez DR7, Wright GM8, Melloni G9, Milano MT10, Sole CV11, De Pas TM12, Carter DL13, Warner AJ1, Rodrigues GB14.

Ann Surg Oncol. 2014 Jun;21(6):2083-90. doi: 10.1245/s10434-014-3540-x. Epub 2014 Feb 13.
Pretreatment Clinical Mediastinal Nodal Bulk and Extent do not Influence Survival in N2-Positive Stage IIIA Non-small Cell Lung Cancer Patients Treated with Trimodality Therapy
Lee H11, Ahn YC, Pyo H, Kim B, Oh D, Nam H, Lee E, Sun JM, Ahn JS, Ahn MJ, Park K, Choi YS, Kim J, Zo JI, Shim YM.

Head Neck. 2014 Apr;36(4):499-504. doi: 10.1002/hed.23328. Epub 2013 Jun 18.
Tumor volume reduction rate measured during adaptive definitive radiation therapy as a potential prognosticator of locoregional control in patients with oropharyngeal cancer
Lee H11, Ahn YC, Oh D, Nam H, Kim YI, Park SY.

Cancer Res Treat. 2014 Apr;46(2):148-57. doi: 10.4143/crt.2014.46.2.148. Epub 2014 Apr 22.
Impact on Loco-regional Control of Radiochemotherapeutic Sequence and Time to Initiation of Adjuvant Treatment in Stage II/III Rectal Cancer Patients Treated with Postoperative Concurrent Radiochemotherapy
Kim H11, Chie EK2, Ahn YC3, Kim K2, Park W3, Yoon WS4, Huh SJ3, Ha SW2.

CANCER IMAGING, APR 22 2014, 14, 10.1186/1470-7330-14-2
Prognostic value of volumetric metabolic parameters measured by [F-18]Fluorodeoxyglucose-positron emission tomography/computed tomography in patients with small cell lung cancer
Park1, SB, Choi, JY, Moon, SH, Yoo, J, Kim, H, Ahn, YC, Ahn, MJ, Park, K, Kim, BT

PLoS One. 2014 Feb 26;9(2):e88598. doi: 10.1371/journal.pone.0088598. eCollection 2014.
Quantitative CT Variables Enabling Response Prediction in Neoadjuvant Therapy with EGFR-TKIs: Are They Different from Those in Neoadjuvant Concurrent Chemoradiotherapy
Chong Y11, Kim JH1, Lee HY1, Ahn YC2, Lee KS1, Ahn MJ3, Kim J4, Shim YM4, Han J5, Choi YL5.

Med Phys.?2014 Feb;41(2):021712. doi: 10.1118/1.4860155.
Dosimetric effects of multileaf collimator leaf width on intensity-modulated radiotherapy for head and neck cancer
Hong CS11,?Ju SG1,?Kim M1,?Kim JI2,?Kim JM1,?Suh TS3,?Han Y1,?Ahn YC1,?Choi DH1,?Nam H2,?Park HC1.

Eur J Nucl Med Mol Imaging. 2014 Jan;41(1):50-8. doi: 10.1007/s00259-013-2530-8. Epub 2013 Aug 16.
Volume-based assessment by F-18-FDG PET/CT predicts survival in patients with stage III non-small-cell lung cancer
Hyun SH11, Ahn HK, Kim H, Ahn MJ, Park K, Ahn YC, Kim J, Shim YM, Choi JY.

J Cancer Res Clin Oncol. 2013 Dec;139(12):2089-96. doi: 10.1007/s00432-013-1531-0. Epub 2013 Oct 10.
A survey of patterns of practice on palliative radiation therapy for bone metastasis in Korea
Chung Y11, Koom WS, Ahn YC, Park HC, Kim HJ, Yoon SM, Shin S, Lee YJ.

Ann Oncol. 2013 Aug;24(8):2088-92. doi: 10.1093/annonc/mdt140. Epub 2013 Apr 16.
Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer(dagger)
Sun JM11, Ahn YC, Choi EK, Ahn MJ, Ahn JS, Lee SH, Lee DH, Pyo H, Song SY, Jung SH, Jo JS, Jo J, Sohn HJ, Suh C, Lee JS, Kim SW, Park K.

J Thorac Oncol. 2013 May;8(5):624-9. doi: 10.1097/JTO.0b013e31828cb6db.
Hypofractionated Three-Dimensional Conformal Radiation Therapy Alone for Centrally Located cT1-3N0 Non-Small-Cell Lung Cancer
Oh D11, Ahn YC, Kim B, Pyo H.

Yonsei Med J. 2012 Nov 1;53(6):1120-7. doi: 10.3349/ymj.2012.53.6.1120.
High Dose Involved Field Radiation Therapy as Salvage for Loco-Regional Recurrence of Non-Small Cell Lung Cancer
Bae SH11, Ahn YC, Nam H, Park HC, Pyo HR, Shim YM, Kim J, Kim K, Ahn JS, Ahn MJ, Park K.

Cancer Res Treat. 2012 Sep;44(3):166-72. doi: 10.4143/crt.2012.44.3.166. Epub 2012 Sep 30.
Is There a Role of Postoperative Radiation Therapy in Completely Resected Stage I/II Thymic Epithelial Tumor
Oh D11, Ahn YC, Kim K, Kim J, Shim YM, Han J.

Clin Exp Otorhinolaryngol. 2012 Jun;5(2):94-100. doi: 10.3342/ceo.2012.5.2.94. Epub 2012 Jun 12.
Definitive Radiation Therapy for Early Glottic Cancer: Experience of Two Fractionation Schedules
Kim TG11, Ahn YC, Nam HR, Chung MK, Jeong HS, Son YI, Baek CH.

Med Phys. 2012 May;39(5):2396-404. doi: 10.1118/1.3700734.
Development of a video-guided real-time patient motion monitoring system
Ju SG11, Huh W, Hong CS, Kim JS, Shin JS, Shin E, Han Y, Ahn YC, Park HC, Choi DH.

Acta Oncol. 2012 May;51(5):596-602. doi: 10.3109/0284186X.2012.681698. Epub 2012 May 1.
Potentially curative stereotactic body radiation therapy (SBRT) for single or oligometastasis to the lung
Oh D11, Ahn YC, Seo JM, Shin EH, Park HC, Lim do H, Pyo H.

Indian J Exp Biol. 2012 Mar;50(3):195-200.
Protective effect of triphala on radiation induced acute intestinal mucosal damage in Sprague Dawley rats
Yoon WS11, Kim CY, Yang DS, Park YJ, Park W, Ahn YC, Kim SH, Kwon GY.

Introduction of intensity modulated radiation therapy
Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):507-12. doi: 10.1016/j.ijrobp.2009.07.1706. Epub 2010 Jan 7.
INVOLVED-LESION RADIATION THERAPY AFTER CHEMOTHERAPY IN LIMITED-STAGE HEAD-AND-NECK DIFFUSE LARGE B CELL LYMPHOMA
Yu JI11, Nam H, Ahn YC, Kim WS, Park K, Kim SJ.

Med Phys.?2010 Jun;37(6):2925-33.
Comparison of film dosimetry techniques used for quality assurance of intensity modulated radiation therapy
Ju SG11,?Han Y,?Kum O,?Cheong KH,?Shin EH,?Shin JS,?Kim JS,?Ahn YC.

Clin Exp Otorhinolaryngol. 2010 Jun;3(2):96-101. doi: 10.3342/ceo.2010.3.2.96. Epub 2010 Jun 30.
Treatment Results of Major Salivary Gland Cancer by Surgery with or without Postoperative Radiation Therapy
Noh JM11, Ahn YC, Nam H, Park W, Baek CH, Son YI, Jeong HS.

J Thorac Oncol. 2010 Apr;5(4):526-32. doi: 10.1097/JTO.0b013e3181cbf622.
Results and Prognostic Factors of Hypofractionated Stereotactic Radiation Therapy for Primary or Metastatic Lung Cancer
Kim H11, Ahn YC, Park HC, Lim do H, Nam H.

Cancer. 2009 Aug 15;115(16):3699-708. doi: 10.1002/cncr.24414.
Therapeutic Effect of Recombinant Human Epidermal Growth Factor (RhEGF) on Mucositis in Patients Undergoing Radiotherapy, With or Without Chemotherapy, for Head And Neck Cancer A Double-blind Placebo-controlled Prospective Phase 2 Multi-institutional Clinical Trial
Wu HG11, Song SY, Kim YS, Oh YT, Lee CG, Keum KC, Ahn YC, Lee SW.

Jpn J Clin Oncol. 2009 Mar;39(3):151-7. doi: 10.1093/jjco/hyn158. Epub 2009 Feb 3.
Prediction of Radiation Pneumonitis Following High-dose Thoracic Radiation Therapy by 3 Gy/fraction for Non-small Cell Lung Cancer: Analysis of Clinical and Dosimetric Factors
Oh D11, Ahn YC, Park HC, Lim do H, Han Y.

Radiother Oncol. 2009 Feb;90(2):236-41. doi: 10.1016/j.radonc.2008.09.011. Epub 2008 Oct 22.
Prognostic significance of anatomic subsites: Results of radiation therapy for 66 patients with localized orbital marginal zone B cell lymphoma
Nam H11, Ahn YC, Kim YD, Ko Y, Kim WS.

Med Phys. 2008 Jun;35(6):2519-27.
Dosimetry in an IMRT phantom designed for a remote monitoring program
Han Y11, Shin EH, Lim C, Kang SK, Park SH, Lah JE, Suh TS, Yoon M, Lee SB, Cho SH, Ibbott GS, Ju SG, Ahn YC.

Jpn J Clin Oncol. 2008 Feb;38(2):92-8. doi: 10.1093/jjco/hym159. Epub 2008 Feb 11.
High-dose thoracic radiation therapy at 3.0 Gy/fraction in inoperable stage I/II non-small cell lung cancer
Kim B11, Ahn YC, Lim do H, Nam HR.

Cancer Lett. 2007 Dec 8;258(1):90-7.
Nongastric marginal zone B-cell lymphoma: A prognostic model from a retrospective multicenter study
Oh SY11, Kwon HC, Kim WS, Park YH, Kim K, Kim HJ, Kwon JM, Lee J, Ko YH, Ahn YC, Oh SJ, Lee SI, Bang SM, Kim JH, Park J, Ryoo BY, Lee SS, Kim HY, Park K, Kim HJ.

Yonsei Med J. 2007 Oct 31;48(5):827-32.
Anal canal carcinoma: Experience from a single Korean institution
Lee WS11, Chun HK, Lee WY, Yun SH, Yun H, Cho YB, Kang WK, Park YS, Huh SJ, Ahn YC, Park W.

Lung Cancer. 2007 Mar;55(3):329-36. Epub 2006 Dec 8.
Analyses on prognostic factors following tri-modality therapy for stage IIIa non-small cell lung cancer
Kim KJ11, Ahn YC, Lim do H, Han J, Park K, Park JO, Kim K, Kim J, Shim YM.

"Yonsei Med J. 2006 Aug 31;47(4):571-4."
Lung metastasis from an immature teratoma of the nasal cavity masquerading as small cell carcinoma of the lung
Kang MK11, Ahn YC, Park JO, Han J, Lee KS.

J Korean Med Sci. 2006 Apr;21(2):229-35.
Preoperative concurrent radiochemotherapy and surgery for stage IIIA non-small cell lung cancer
Kang MK11, Ahn YC, Lim DH, Park K, Park JO, Shim YM, Kim J, Kim K.

Haematologica. 2006 Mar;91(3):427-8. Epub 2006 Feb 17.
The effect of pre-irradiation dose intense CHOP on anthracyline resistance in localized nasal NK/T-cell lymphoma
Lee SH1, Ahn YC, Kim WS, Ko YH, Kim K, Park K.

Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1559-64.
Real-time monitoring of a digestive tract marker to reduce adverse effects of moving organs at risk (OAR) in radiotherapy for thoracic and abdo